News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
93,614 Results
Type
Article (11111)
Company Profile (23)
Press Release (82474)
Multimedia
Podcasts (93)
Webinars (12)
Section
Business (35119)
Career Advice (555)
Deals (6078)
Drug Delivery (108)
Drug Development (13044)
Employer Resources (44)
FDA (2053)
Job Trends (2196)
News (51235)
Policy (4957)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Standard (3)
Academia (179)
Accelerated approval (14)
ADA (13)
Adcomms (21)
Allergies (42)
Alliances (8298)
ALS (52)
Alzheimer's disease (350)
Antibody-drug conjugate (ADC) (139)
Approvals (2009)
Artificial intelligence (218)
ASCO (58)
Autoimmune disease (79)
Automation (10)
Bankruptcy (55)
Belgium (2)
Best Places to Work (1224)
BIO (21)
Biologics (3)
BIOSECURE Act (9)
Biosimilars (91)
BioSpace Insights (63)
Biotechnology (14)
Bispecific (2)
Bladder cancer (40)
Brain cancer (11)
Breast cancer (77)
Cancer (1069)
Cardiovascular disease (175)
Career advice (469)
Career pathing (30)
CAR-T (62)
CDC (13)
CDMO (82)
Celiac Disease (1)
Cell-line development (1)
Cell therapy (162)
Cervical cancer (5)
Clinical research (11332)
Collaboration (568)
Commercialization (8)
Company closure (3)
Compensation (128)
Complete response letters (40)
COVID-19 (489)
CRISPR (11)
C-suite (363)
Cystic fibrosis (17)
Data (1099)
Decentralized trials (1)
Denatured (14)
Depression (42)
Dermatology (43)
Diabetes (133)
Diagnostics (560)
Digital health (13)
Diversity (8)
Diversity, equity & inclusion (11)
Drug discovery (135)
Drug pricing (167)
Drug shortages (25)
Duchenne muscular dystrophy (89)
Earnings (10268)
Editorial (48)
Employer branding (6)
Employer resources (50)
Events (12800)
Executive appointments (288)
FDA (2622)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (376)
Gene editing (35)
Generative AI (38)
Gene therapy (157)
GLP-1 (506)
Government (870)
Grass and pollen (1)
Guidances (48)
Healthcare (1573)
Hematology (25)
HIV (19)
Huntington's disease (21)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (21)
Immunology and inflammation (173)
Immuno-oncology (42)
Indications (23)
Infectious disease (583)
Inflammatory bowel disease (40)
Inflation Reduction Act (6)
Influenza (30)
Intellectual property (47)
Interviews (79)
IPO (2150)
IRA (42)
Job creations (854)
Job search strategy (394)
JPM (40)
Kidney cancer (3)
Kidney disease (20)
Labor market (85)
Layoffs (245)
Leadership (33)
Legal (1144)
Licensing (15)
Liver cancer (20)
Longevity (7)
Lung cancer (152)
Lung diease (6)
Lymphoma (96)
Machine learning (17)
Management (24)
Manufacturing (421)
Marketing (2)
MASH (57)
Medical device (425)
Medtech (433)
Mergers & acquisitions (4135)
Metabolic disorders (603)
mRNA (62)
Multiple sclerosis (45)
NASH (9)
Netherlands (4)
Neurodegenerative disease (112)
Neuropsychiatric disorders (52)
Neuroscience (768)
Neurotech (1)
NextGen: Class of 2026 (653)
Non-profit (158)
Now hiring (58)
Obesity (420)
Opinion (173)
Ovarian cancer (24)
Pain (75)
Pancreatic cancer (65)
Parkinson's disease (72)
Partnered (11)
Patents (137)
Patient advocacy (1)
Patient recruitment (102)
Patient selection (3)
Peanut (7)
People (10776)
Peptides (1)
Pharmaceutical (12)
Pharmacy benefit managers (22)
Phase 1 (3117)
Phase 2 (5108)
Phase 3 (4423)
Pipeline (1838)
Policy (199)
Postmarket research (296)
Preclinical (1062)
Press Release (4)
Prostate cancer (60)
Psychedelics (34)
Radiopharmaceuticals (95)
Rare diseases (314)
Real estate (983)
Recruiting (22)
Regulatory (4219)
Reports (16)
Research institute (228)
Resumes & cover letters (99)
Rett syndrome (1)
RNA editing (10)
RSV (30)
Schizophrenia (73)
Series A (69)
Series B (45)
Service/supplier (2)
Sickle cell disease (18)
Special edition (23)
Spinal muscular atrophy (44)
Sponsored (9)
Startups (760)
Stomach cancer (10)
Substance use disorders (4)
Supply chain (56)
Tariffs (93)
The Weekly (77)
Vaccines (226)
Venture capital (94)
Weight loss (348)
Women's health (33)
Worklife (10)
Date
Last 7 days (97)
Last 30 days (389)
Last 365 days (4788)
2026 (3666)
2025 (4790)
2024 (5251)
2023 (5762)
2022 (8217)
2021 (7754)
2020 (6755)
2019 (5525)
2018 (4402)
2017 (6240)
2016 (5430)
2015 (5405)
2014 (3357)
2013 (2885)
2012 (2895)
2011 (2867)
2010 (2403)
Location
Africa (189)
Alabama (6)
Arizona (18)
Arkansas (1)
Asia (9630)
Australia (826)
California (1450)
Canada (647)
China (393)
Colorado (91)
Connecticut (121)
Delaware (51)
Europe (21159)
Florida (408)
Georgia (15)
Hawaii (1)
Idaho (3)
Illinois (127)
India (62)
Indiana (64)
Iowa (2)
Japan (237)
Kansas (48)
Kentucky (3)
Louisiana (3)
Maryland (244)
Massachusetts (1216)
Michigan (28)
Minnesota (24)
Mississippi (2)
Missouri (4)
Montana (1)
Nebraska (3)
Nevada (9)
New Hampshire (3)
New Jersey (873)
New Mexico (16)
New York (413)
North Carolina (209)
Northern California (595)
Ohio (75)
Oklahoma (1)
Oregon (9)
Pennsylvania (435)
Puerto Rico (20)
Rhode Island (8)
South America (239)
South Carolina (3)
Southern California (706)
Tennessee (18)
Texas (146)
United States (6035)
Utah (22)
Virginia (25)
Washington D.C. (19)
Washington State (198)
West Virginia (1)
Wisconsin (16)
Wyoming (1)
93,614 Results for "rocket pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rocket Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences
September 3, 2026
·
5 min read
Gene therapy
Rocket’s Gene Therapy Wins FDA Greenlight, Clearing Way for Future Products
While the accelerated approval unlocks only a small market opportunity for Rocket Pharmaceuticals, it will give the biotech a chance to prepare for future product launches, according to Jefferies.
March 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease
September 15, 2026
·
7 min read
Press Releases
Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress
August 10, 2026
·
18 min read
Press Releases
Rocket Pharmaceuticals to Participate in Upcoming June 2026 Investor Conferences
May 28, 2026
·
4 min read
Press Releases
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
April 28, 2026
·
6 min read
Press Releases
Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million
June 12, 2026
·
4 min read
Press Releases
Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease
August 3, 2026
·
7 min read
Press Releases
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
May 8, 2026
·
15 min read
Gene therapy
Rocket Aborts FDA Filing for Rare Blood Disease Gene Therapy
Rocket Pharmaceuticals’ strategic realignment initiative in July pulled funding from fanca-cel, which the biotech was developing for Fanconi anemia.
October 6, 2025
·
2 min read
·
Tristan Manalac
1 of 9,362
Next
